Thomas Strüngmann
Thomas Strüngmann founded generic drug maker Hexal AG in 1986. In 2005, he and his brother Andreas sold Hexal for $6.7B. They earned $8B on their stake in BioNTech SE, the German company developing the Pfizer vaccine. They own approximately 50% of the company as well as significant ownership in 4SC and Immatics. He currently has the largest health-care earned fortune with his brother.
From *.wikipedia.org,
Información General
.
Hombre
Fecha de nacimiento
01 de enero, 1950
Edad
76
Zodíaco
Capricornio
Redes sociales , Enlaces
Interés
Loading Chart...
Parientes
Listas